Auckland University of Technology
National Institute for Stroke and Applied Neurosciences
Professor Feigin is Professor of Neurology and Epidemiology and the Director of the National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, New Zealand, and Affiliate Professor of the University of Washington, USA. He is also Honorary Professor of the Novosibirsk State Medical University, Russia, a Visiting Professor of the Capital Medical University of China, a Fellow of the Royal Society of New Zealand, American Academy of Neurology, and Russian Academy of Sciences. Professor Feigin’s prime research interest is in the epidemiology, prevention and management of stroke, dementia and traumatic brain injury. He published over 420 journal articles, totalling over 200,000 citations. Valery Feigin is one of the 1% most cited scientists worldwide (Web of Science h-index in June 2021 was 91). ). Just from the last year (2020) to 2021 his citation rate is one every 15 minutes, and rising.

Presenter of 3 Presentations

Introduction to WSO Award for Contributions to Clinical Stroke Research

Session Type
Plenary Session
Date
28.10.2021, Thursday
Session Time
11:30 - 13:30
Room
PLENARY
Lecture Time
11:35 - 11:40

Realistic and Aspirational Stroke Prevention Goals

Session Type
Plenary Session
Date
29.10.2021, Friday
Session Time
11:30 - 13:00
Room
PLENARY
Lecture Time
12:12 - 12:26

Abstract

Abstract Body

Theoretically, up to 90% of all strokes could prevented if all individual risk factors could be set at the theoretical minimum risk exposure level, e.g., zero level of exposure to smoking, alcohol intake, or systolic blood pressure of 110-115 mmHg across the whole population, etc. However, in practice this level of reduction of exposure to risk factors across the world is hardly achievable, at least for the near future. Therefore, in practice realistic goals for primary stroke prevention should be informed by results of reliable randomised controlled trials (RCTs) and modelling, including meta-analysis and systematic reviews. It is also important to consider primary prevention goals that are achievable via population-wide prevention strategies, individual prevention strategies, and both strategies combined. In my presentation, I would like to give an overview of currently available primary stroke prevention strategies, outline evidence from RCTs, difficulties and opportunities for effective primary stroke prevention, realistic medical and economic benefits of stroke prevention, and the most promising ways to improve the situation.

Hide

Policy and Pragmatic Solutions to Improve Primary and Secondary Prevention of Stroke

Session Type
Joint Session
Date
28.10.2021, Thursday
Session Time
15:45 - 17:15
Room
JOINT SESSIONS
Lecture Time
16:02 - 16:19

Abstract

Abstract Body

The 2-3-fold increase in stroke burden across the globe clearly indicates that primary stroke prevention strategies are either not used widely enough or not effective. There are also major between-country gaps in the proportion of recurrent strokes, with some countries (even some developed countries, such as New Zealand) not showing a trend towards improvement at all or very little improvement over the last 30 years. This is suggestive of insufficient implementation of proven effective secondary stroke prevention strategies across the globe, with developing countries suffering the most. This unsatisfactory situation requires analysis of causes of failing primary and secondary stroke prevention strategies and outlining directions and action plans for improving the situation.

In my presentation I will discuss the current trends in stroke burden and risk factors in the world and focus on promising, validated and affordable primary stroke prevention strategies that could be applied across the globe, using strategies outlined in the recent World Stroke Organization Declaration on primary stroke and dementia prevention. These include population-wide and mass individual motivational prevention strategies via widely available and free to use eHealth technologies, such as the Stroke Riskometer app, community interventions by nurses and health volunteers and polypill for people at risk of stroke. I argue that the best way for implementing these strategies is through the support of the WHO and other major international health organisations for these strategies, followed by their inclusion into national and international stroke prevention guidelines endorsed by the national Ministries of Health.

Hide